Currently out of the existing stock ratings of Kevin Heal, 63 are a BUY (84%), 11 are a HOLD (14.67%), 1 are a SELL (1.33%).

Kevin Heal

Work Performance Price Targets & Ratings Chart

Analyst Kevin Heal, carries an average stock price target met ratio of 69.63% that have a potential upside of 23.47% achieved within 360 days. Previously, Kevin Heal worked at ARGUS.

Kevin Heal’s has documented 141 price targets and ratings displayed on 20 stocks. The coverage was on the Financial Services sector.

Most recent stock forecast was given on MKTX, MarketAxess Holdings at 24-Aug-2025.

Wall Street Analyst Kevin Heal

Analyst best performing recommendations are on CMA (COMERICA).
The best stock recommendation documented was for CMA (COMERICA) at 10/30/2023. The price target of $52 was fulfilled within 45 days with a profit of $17 (48.57%) receiving and performance score of 10.79.

Average potential price target upside

of $46.22 (27.38%) on CME (CME GROUP).
of $36.88 (18.83%) on AMP (AMERIPRISE FINANCIAL).
of $29.4 (27.63%) on ICE (INTERCONTINENTAL EXCHANGE).

AGNC AGNC Investment Corp AMP Ameriprise Financial CBOE Cboe Global Markets CFG Citizens Financial Group NLY Annaly Capital Management NRZ New Residential Investment Corp ZION Zions Bancorporation CB Chubb Ltd CME CME Group NDAQ Nasdaq RF Regions Financial TRV The Travelers Companies ALL The Allstate HBAN Huntington Bancshares RKT Rocket Companies CMA Comerica MET MetLife UWMC UWM Holdings Corp ICE Intercontinental Exchange MKTX MarketAxess Holdings

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Kenneth Lee (RBC)